Amyloid β protein 1-42/43 (Aβ 1-42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study

Akira Tamaoka, Naoya Sawamura, Asano Odaka, Nobuhiro Suzuki, Hidehiro Mizusawa, Shin'ichi Shoji, Hiroshi Mori

Research output: Contribution to journalArticle

62 Citations (Scopus)


Diffuse plaques are immature and amorphous senile plaques and believed to be in the initial phase of plaque formation. In contrast to amyloid angiopathy and the plaque core amyloid, diffuse plaques failed to be purified in preserved forms from the brain. Here, we studied the diffuse plaques in the cerebellar region of the Alzheimer's disease brain based on immunocytochemistry and ELISA using two different monoclonal antibodies specifically recognizing the car{ballot box}yl termini of Aβ molecules (BA27 for Aβ 1-40 and BC05 for Aβ 1-42/43). We found that the amount of Aβ 1-40 was in proportion to the staining degree on amyloid angiopathy by immunohistochemistry. We found that Aβ 1-42/43 comprised diffuse plaques as the major component in the cerebella of AD brains. Taking these findings into consideration, diffuse plaques, the earliest pathological change in the brain with AD, are concluded to be composed mainly of Aβ 1-42/43, implicating the critical importance of this kind of Aβ species deposition in the pathogenesis of AD.

Original languageEnglish
Pages (from-to)151-156
Number of pages6
JournalBrain Research
Issue number1
Publication statusPublished - 1995 May 8
Externally publishedYes



  • Alzheimer's disease
  • Amyloid angiopathy
  • Amyloid β protein
  • Cerebellum
  • Diffuse plaque
  • Enzyme-linked immunosorbent assay
  • Immunocytochemistry

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this